Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies
By Ciaran McEvoy (March 26, 2013, 3:33 PM EDT) -- Takeda Pharmaceutical Co.'s diabetes drug Actos was "the most substantial causative factor" in a California man's terminal bladder cancer, a urologist testifying for the plaintiff told a Los Angeles jury Tuesday in the first product liability trial of its kind.
Dr. Norm D. Smith, an associate professor of surgery and urology at the University of Chicago Medical Center, testified Tuesday that plaintiff Jack Cooper's taking of Actos from 2006 to 2011 was the primary reason he became ill.
Smith told jurors under direct examination by plaintiffs lawyer Michael J. Miller of The Miller Firm LLC that Cooper, a San Diego-area resident,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!